Multispectral photoacoustic microscopy and NIR-II fluorescence imaging of TREM2-positive microglia in Aβ-driven

Hsuan Lo1,2, Shiying Li1,2, Jiali Chen2,3

  • 1Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Fundamental Research
|August 1, 2026
PubMed

Insights

Researchers developed a novel dual-modal imaging probe (TREM2-ICG) to track microglial responses to amyloid-beta plaques in Alzheimer's disease (AD) models. This technique offers unprecedented spatiotemporal resolution for studying neuroinflammation in vivo.

Area of Science:

  • Neuroscience
  • Biomedical Imaging
  • Alzheimer's Disease Research

Background:

  • Monitoring microglial activation in neurodegeneration is challenging.
  • Existing imaging methods lack the spatiotemporal resolution and field of view to track amyloid-beta (Aβ)-linked microglial dynamics.
  • Triggering receptor expressed on myeloid cells 2 (TREM2) is a key Alzheimer's disease (AD) biomarker involved in Aβ clearance and neuroinflammation.

Purpose of the Study:

  • To develop a dual-modal imaging probe for robust in vivo photoacoustic and near-infrared-II (NIR-II) fluorescence imaging of TREM2-expressing microglia.
  • To track Aβ-linked microglial dynamics with high spatiotemporal resolution across a wide field of view.
  • To investigate AD pathogenesis by visualizing TREM2-microglia plaque engagement and microglial responses to Aβ.

Main Methods:

  • Conjugation of a TREM2-specific antibody with indocyanine green (ICG) to create the TREM2-ICG probe.
  • Multi-wavelength photoacoustic microscopy (532 nm for hemoglobin, 559 nm for Aβ probe AOI987, 780 nm for TREM2-ICG).
  • Time-resolved NIR-II fluorescence imaging (30 frames/sec) for tracking microglial displacement and chemotaxis.

Main Results:

  • The TREM2-ICG probe enabled robust in vivo imaging of peri-plaque microglia using photoacoustic and NIR-II fluorescence modalities.
  • High-speed NIR-II imaging revealed rapid, Aβ-oligomer-induced microglial displacement, demonstrating chemotaxis.
  • Multiscale imaging resolved cortex-wide Aβ-microglial interactions, overcoming limitations of confocal and two-photon microscopy.

Conclusions:

  • The developed dual-modal TREM2-ICG probe provides a powerful tool for in vivo tracking of microglial responses to Aβ.
  • This imaging approach offers wide-field, high-speed, and deep-penetration capabilities for studying AD pathogenesis.
  • The findings highlight the potential for investigating AD-specific mechanisms and therapeutic targets through advanced imaging techniques.

Related Concept Videos